HealthcareServices

CRISPR-Based Diagnostics Market Forecast 2026–2035: How to Leverage Market Growth

February 23, 2026February 24, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the crispr-based diagnostics market from 2026–2035 with trusted insights from The Business Research Company

What is the expected shift in the CRISPR-Based Diagnostics Market’s size between 2026 and 2030?

The crispr-based diagnostics market has experienced significant expansion recently. Projections indicate a rise from $5.1 billion in 2025 to $6.01 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 17.8%. This past growth is attributable to factors such as the demand for quick and precise diagnostics, the shortcomings of conventional molecular testing, the increased diagnostic requirements spurred by pandemics, developments in crispr detection techniques, and the academic endorsement of crispr diagnostics.

The crispr-based diagnostics market is projected to experience swift expansion in the coming years. By 2030, its valuation is anticipated to reach $11.45 billion, demonstrating a compound annual growth rate (CAGR) of 17.5%. This anticipated growth during the forecast period is fueled by several factors, including the proliferation of decentralized testing approaches, an increasing need for prompt disease identification, the broadening scope of point-of-care diagnostic solutions, seamless incorporation with digital health platforms, and its growing application in oncology and genetic screening. Furthermore, key trends shaping the market during this period encompass the escalating acceptance of rapid molecular diagnostics, the broadening availability of point-of-care testing methods, enhanced deployment in identifying infectious diseases, its fusion with isothermal amplification technologies, and the evolution of personalized diagnostic uses.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20734&type=smp

Which Drivers Are Shaping Strategic Decisions In The CRISPR-Based Diagnostics Market?

The escalating prevalence of infectious diseases is anticipated to drive the expansion of the CRISPR-based diagnostics market moving forward. These illnesses are caused by pathogenic microorganisms such as bacteria, viruses, fungi, or parasites, capable of spreading directly or indirectly between individuals, via contaminated surfaces, food, water, or vectors like insects. The frequency of infectious diseases is increasing due to factors such as globalization, antibiotic resistance, climate change, urbanization, population growth, habitat destruction, and insufficient healthcare access. CRISPR-based diagnostics improve the battle against infectious diseases by providing rapid and accurate pathogen detection, thereby facilitating early diagnosis, timely intervention, and effective containment measures. For instance, in August 2024, according to the data published by the UK Health Security Agency, a UK-based executive agency, in England, the UK Health Security Agency (UKHSA) reported 368 measles cases in 2023, marking a nearly sevenfold increase from the 53 cases reported in 2022, with the West Midlands and London accounting for 44% and 33% of the cases, respectively. Consequently, the rising incidence of infectious diseases is propelling the CRISPR-based diagnostics market.

What Segment Classifications Make Up The CRISPR-Based Diagnostics Market?

The crispr-based diagnostics market covered in this report is segmented –

1) By Product: Kits, Buffer Solutions, Software, Other Products

2) By Technique: Recombinase Polymerase Amplification (RPA), Loop-Mediated Isothermal Amplification (LAMP), Other Techniques

3) By Disease: Infectious Diseases, Non-Infectious Diseases

4) By End-User: Hospitals, Diagnostic Centers, Biotechnology Companies, Academic And Research Institutes, Other End-Users

Subsegments:

1) By Kits: CRISPR Detection Kits, CRISPR Amplification Kits, CRISPR-Based Assay Kits

2) By Buffer Solutions: CRISPR Reaction Buffers, CRISPR Lysis Buffers

3) By Software: CRISPR Data Analysis Software, CRISPR Design Software, CRISPR Diagnostic Platforms Software

4) By Other Products: CRISPR Enzymes, CRISPR Reagents, CRISPR-Based Probes

Which Trends Are Influencing The Performance And Direction Of The CRISPR-Based Diagnostics Market?

Key companies operating within the CRISPR-based diagnostics market are actively pursuing strategic partnerships to improve access to rapid and accurate diagnostic capabilities through CRISPR-based point-of-care tests. A strategic partnership represents a long-term collaboration between two or more organizations that pool resources and expertise to achieve shared objectives and enhance their competitive advantage. For instance, in August 2023, CrisprBits Private Limited, an India-based biotechnology company, declared a strategic collaboration with Molbio Diagnostics, an India-based molecular diagnostics company, focused on developing CRISPR-based Point-of-Care Tests (POCTs). This collaborative effort aims to produce swift, precise, and cost-effective diagnostic tools leveraging CRISPR technology for detecting pathogens and genetic markers. These POCTs are intended to boost diagnostic accessibility in diverse settings, including areas with limited resources, while ensuring quick and accurate disease detection. The partnership combines CrisprBits’ proficiency in CRISPR-based platforms with Molbio’s manufacturing and distribution strengths to introduce these tests to a global market.

Which Major Firms Are Strengthening Their Position In The CRISPR-Based Diagnostics Market?

Major companies operating in the crispr-based diagnostics market are Thermo Fisher Scientific Inc., Integrated DNA Technologies Inc., Molbio Diagnostics, Horizon Discovery, Synthego Corporation, Caribou Biosciences, Mammoth Biosciences, Epic Bio, VedaBio, CrisprBits, SNIPR BIOME ApS, TOLO Biotech, Intact Genomics, Agdia Inc., ToolGen Inc., Caspr Biotech, GenScript, Twist Bioscience, Revvity Discovery Limited, Danaher Corporation, Scope Biosciences, CRISPR Diagnostics, Gene Editing Institute, Aptitude Medical Systems, Qiagen, Abingdon Health

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/crispr-based-diagnostics-global-market-report

Which Region Is Anticipated To See The Fastest Growth In The CRISPR-Based Diagnostics Market?

North America was the largest region in the CRISPR-based diagnostics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the crispr-based diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized CRISPR-Based Diagnostics Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=20734&type=smp

Browse Through More Reports Similar to the Global CRISPR-Based Diagnostics Market 2026, By The Business Research Company

Plant Breeding And Crispr Plants Market Report 2026

https://www.thebusinessresearchcompany.com/report/plant-breeding-and-crispr-plants-global-market-report

Crispr Gene Editing Market Report 2026

https://www.thebusinessresearchcompany.com/report/crispr-gene-editing-global-market-report

Crispr And Cas Gene Market Report 2026

https://www.thebusinessresearchcompany.com/report/crispr-and-cas-gene-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795